-+ 0.00%
-+ 0.00%
-+ 0.00%

ATYR PHARMA INC - DOSING FREQUENCY OF 5.0 MG/KG EFZOFITIMOD OR PLACEBO INCREASED TO EVERY THREE WEEKS IN NEXT PHASE 3 TRIAL

Reuters·05/11/2026 20:01:00

Please log in to view news